Market Research Report Store Prima BioMed Ltd (PRR) - Pharmaceuticals & Healthc

Market Research Report Store has been recently published a fresh report"Prima BioMed Ltd (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile-Market Research Report Store＂.It is a professional and in-depth study. Complete Report Available at: @ https://www.marketresearchreportstore.com/ Request a sample, click here [email protected] Description Prima BioMed Ltd (Prima BioMed) is a biotechnology company that develops a range of immunocellular therapeutic products for the treatment of cancer. The company’s pipeline products are based on LAG-3 immune control mechanism which is active in the regulation of the T cell immune response. Its CVac ovarian cancer vaccine is a maintainence therapy vaccine, which is administered post-surgery and post-chemotherapy to delay relapse and control metastases. Prima BioMed’s IMP321 is in clinical development for the treatment of a range of cancer indications. The company collaborates with pharmaceutical and biotech companies for its research and development activities. It has presence in Australia, Germany and France. Prima BioMed is headquartered in Sydney, New South Wales, Australia. Prima BioMed Ltd (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. Scope